دورية أكاديمية
HPV in oropharyngeal cancer: the basics to know in clinical practice.
| العنوان: | HPV in oropharyngeal cancer: the basics to know in clinical practice. |
|---|---|
| المؤلفون: | Elrefaey S; Division of Otolaryngology Head and Neck Surgery, European Institute of Oncology, Milano, Italy; ; Department of Otolaryngology, Head and Neck Surgery, Alexandria University, Alexandria, Egypt;, Massaro MA; Division of Otolaryngology Head and Neck Surgery, European Institute of Oncology, Milano, Italy;, Chiocca S; Department of Experimental Oncology, IFOM-IEO Campus, European Institute of Oncology, Milano, Italy., Chiesa F; Division of Otolaryngology Head and Neck Surgery, European Institute of Oncology, Milano, Italy;, Ansarin M; Division of Otolaryngology Head and Neck Surgery, European Institute of Oncology, Milano, Italy; |
| المصدر: | Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale [Acta Otorhinolaryngol Ital] 2014 Oct; Vol. 34 (5), pp. 299-309. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Pacini editore Country of Publication: Italy NLM ID: 8213019 Publication Model: Print Cited Medium: Internet ISSN: 1827-675X (Electronic) Linking ISSN: 0392100X NLM ISO Abbreviation: Acta Otorhinolaryngol Ital Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Pisa : Pacini editore, 1981- |
| مواضيع طبية MeSH: | Carcinoma, Squamous Cell/*virology , Oropharyngeal Neoplasms/*virology , Papillomavirus Infections/*complications, Carcinoma, Squamous Cell/diagnosis ; Carcinoma, Squamous Cell/therapy ; Humans ; Oropharyngeal Neoplasms/diagnosis ; Oropharyngeal Neoplasms/therapy ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/therapy ; Papillomavirus Vaccines |
| مستخلص: | The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of the reduced prevalence of smoking. Human papilloma virus (HPV) infection, and in particular type 16 (HPV-16), is now recognized as a significant player in the onset of HPV positive OPSCC, with different epidemiological, clinical, anatomical, radiological, behavioural, biological and prognostic characteristics from HPV negative OPSCC. Indeed, the only subsite in the head and neck with a demonstrated aetiological viral link is, at present, the oropharynx. These observations lead to questions regarding management choices for patients based on tumour HPV status with important consequences on treatment, and on the role of vaccines and targeted therapy over the upcoming years. |
| References: | Int J Cancer. 2013 Jan 15;132(2):335-44. (PMID: 22700466) Head Neck Pathol. 2012 Jul;6 Suppl 1:S98-103. (PMID: 22782229) Int J Cancer. 2003 Nov 1;107(2):244-9. (PMID: 12949801) Oral Oncol. 2009 Aug;45(8):e62-6. (PMID: 19442570) Eur J Cancer Prev. 2000 Dec;9(6):433-7. (PMID: 11201683) Cancer. 2007 Oct 1;110(7):1429-35. (PMID: 17724670) Otolaryngol Clin North Am. 2012 Aug;45(4):845-61. (PMID: 22793856) Oral Oncol. 2003 Jan;39(1):31-6. (PMID: 12457719) Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75. (PMID: 15734974) Cancer. 2001 Dec 1;92(11):2875-84. (PMID: 11753961) Br J Cancer. 2013 Mar 19;108(5):1157-62. (PMID: 23403821) Cancer. 2005 May 1;103(9):1843-9. (PMID: 15772957) Head Neck. 2011 Apr;33(4):573-80. (PMID: 21425382) Semin Oncol. 2004 Dec;31(6):744-54. (PMID: 15599852) Arch Otolaryngol Head Neck Surg. 2009 Feb;135(2):180-8. (PMID: 19221247) Int J Cancer. 2004 Feb 20;108(5):766-72. (PMID: 14696105) Clin Cancer Res. 2009 Nov 15;15(22):6758-62. (PMID: 19861444) ISRN Oncol. 2012;2012:945162. (PMID: 22606380) Acta Otorhinolaryngol Ital. 2009 Jun;29(3):119-26. (PMID: 20140157) Gynecol Oncol. 2010 Jun;118(1 Suppl):S2-7. (PMID: 20494220) Otolaryngol Clin North Am. 2012 Aug;45(4):739-64. (PMID: 22793850) J Clin Oncol. 2009 Apr 20;27(12):1992-8. (PMID: 19289615) J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. (PMID: 18270337) J Clin Oncol. 2011 Nov 10;29(32):4294-301. (PMID: 21969503) Expert Rev Anticancer Ther. 2007 Oct;7(10):1473-86. (PMID: 17944571) N Engl J Med. 2007 May 10;356(19):1944-56. (PMID: 17494927) Ann Oncol. 2011 May;22(5):1071-7. (PMID: 21317223) Adv Cancer Res. 2005;93:59-89. (PMID: 15797444) N Engl J Med. 2001 Apr 12;344(15):1125-31. (PMID: 11297703) Eur Arch Otorhinolaryngol. 2013 Feb;270(2):405-16. (PMID: 22752642) Lancet Oncol. 2010 Aug;11(8):781-9. (PMID: 20451455) Clin Cancer Res. 2010 Feb 15;16(4):1226-35. (PMID: 20145161) Cancer Prev Res (Phila). 2009 Sep;2(9):776-81. (PMID: 19641042) Ann N Y Acad Sci. 2001 Dec;949:333-40. (PMID: 11795372) Oral Oncol. 2004 Mar;40(3):304-13. (PMID: 14747062) Cancer. 2010 May 1;116(9):2166-73. (PMID: 20186832) Cancer Lett. 2010 Feb 28;288(2):149-55. (PMID: 19628331) Acta Otorhinolaryngol Ital. 2013 Apr;33(2):77-87. (PMID: 23853396) AJNR Am J Neuroradiol. 2013 Oct;34(10):2005-9. (PMID: 23660291) Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):276-83. (PMID: 20950953) Radiother Oncol. 2010 Jan;94(1):30-5. (PMID: 19910068) Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10978-83. (PMID: 11005870) Acta Otolaryngol. 2007 Sep;127(9):988-92. (PMID: 17712680) Head Neck Pathol. 2012 Jul;6 Suppl 1:S16-24. (PMID: 22782220) J Clin Oncol. 2010 Sep 20;28(27):4142-8. (PMID: 20697079) N Engl J Med. 2004 May 6;350(19):1937-44. (PMID: 15128893) Head Neck Pathol. 2012 Jul;6 Suppl 1:S121-8. (PMID: 22782231) Cancer. 2008 Nov 15;113(10 Suppl):3036-46. (PMID: 18980286) Int J Cancer. 2006 Dec 1;119(11):2620-3. (PMID: 16991119) Cancer. 2008 Nov 15;113(10 Suppl):2901-9. (PMID: 18980273) Prev Med. 2011 Oct;53 Suppl 1:S12-21. (PMID: 21962466) J Clin Oncol. 2000 Jun;18(11):2258-68. (PMID: 10829046) Semin Oncol. 2008 Jun;35(3):286-97. (PMID: 18544443) Prev Med. 2011 Oct;53 Suppl 1:S5-S11. (PMID: 21962471) Int J Cancer. 2008 Jun 15;122(12):2656-64. (PMID: 18360824) Cancer. 2001 Aug 15;92(4):805-13. (PMID: 11550151) Laryngoscope. 2009 Mar;119(3):508-15. (PMID: 19235742) Eur J Cancer Prev. 2004 Apr;13(2):139-42. (PMID: 15100581) J Clin Oncol. 2008 Feb 1;26(4):612-9. (PMID: 18235120) Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. (PMID: 19789295) Int J Cancer. 2014 May 15;134(10):2366-72. (PMID: 24249631) Lancet Oncol. 2009 Oct;10(10):975-80. (PMID: 19796749) J Clin Oncol. 2008 Jul 1;26(19):3128-37. (PMID: 18474878) Radiother Oncol. 2011 Jul;100(1):49-55. (PMID: 21429609) Cancer. 2008 Nov 15;113(10 Suppl):2910-8. (PMID: 18980274) MMWR Morb Mortal Wkly Rep. 2010 May 28;59(20):626-9. (PMID: 20508593) Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):571-8. (PMID: 11597795) Int J Cancer. 2010 Dec 15;127(12):2893-917. (PMID: 21351269) J Clin Oncol. 2008 Jul 20;26(21):3582-9. (PMID: 18559875) Int J Oncol. 2013 Aug;43(2):383-93. (PMID: 23708675) Head Neck. 2008 Jul;30(7):898-903. (PMID: 18383529) Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50. (PMID: 19190158) J Natl Compr Canc Netw. 2011 Jun 1;9(6):665-73. (PMID: 21636538) J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. (PMID: 19276448) Oncogene. 2006 Apr 20;25(17):2558-64. (PMID: 16314836) JAAPA. 2009 Oct;22(10):42-6. (PMID: 19902832) Curr Oncol Rep. 2010 Mar;12(2):115-20. (PMID: 20425596) Clin Cancer Res. 2009 Mar 1;15(5):1779-86. (PMID: 19223504) N Engl J Med. 2010 Jul 1;363(1):24-35. (PMID: 20530316) J Natl Cancer Inst. 2008 Mar 19;100(6):407-20. (PMID: 18334711) J Natl Cancer Inst. 2012 Feb 8;104(3):176. (PMID: 22271770) N Engl J Med. 2006 Feb 9;354(6):567-78. (PMID: 16467544) Semin Radiat Oncol. 2012 Apr;22(2):128-42. (PMID: 22385920) Science. 2011 Aug 26;333(6046):1157-60. (PMID: 21798893) Int J Epidemiol. 2010 Feb;39(1):166-81. (PMID: 20022926) MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24. (PMID: 17380109) MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705-8. (PMID: 22189893) Oncologist. 2013;18(2):180-9. (PMID: 23345545) J Clin Pathol. 2004 May;57(5):449-55. (PMID: 15113849) Lancet. 1999 Oct 23;354(9188):1442-3. (PMID: 10543674) J Natl Cancer Inst. 2000 May 3;92(9):709-20. (PMID: 10793107) Oral Oncol. 2010 Nov;46(11):780-5. (PMID: 20920878) |
| فهرسة مساهمة: | Keywords: Clinical Trial; Head and Neck cancer; Human Papillomavirus; Oropharyngeal cancer; Prevention; Prognosis; Squamous Cell Carcinoma; Treatment; Vaccination Local Abstract: [Publisher, Italian] L'incidenza del carcinoma spinocellulare dell'orofaringe (OPSCC) è in aumento in contrasto con la diminuzione dell'incidenza di carcinomi in altre sedi del distretto cervico-facciale, nonostante la ridotta prevalenza del fumo. L'infezione da Papilloma Virus Umano (HPV), in particolare di tipo 16 (HPV 16), è ora riconosciuto come un importante fattore nell'insorgenza di HPV OPSCC positivo, con diverse caratteristiche radiologiche, epidemiologiche, cliniche, anatomiche, biologiche e prognostiche rispetto all'HPV OPSCC negativo. In effetti l'unica sede del distretto cervico-facciale con un collegamento virale eziologico dimostrato è, attualmente, l'orofaringe. Queste osservazioni portano a domande riguardanti le scelte di gestione per i pazienti in base allo stato del tumore HPV con importanti conseguenze sul trattamento e sul ruolo dei vaccini e terapia mirata per i prossimi anni. |
| المشرفين على المادة: | 0 (Papillomavirus Vaccines) |
| تواريخ الأحداث: | Date Created: 20150225 Date Completed: 20161215 Latest Revision: 20220408 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC4299160 |
| PMID: | 25709145 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1827-675X |
|---|